Beta-blockers in alcohol withdrawal.
Neff
D A
DA
School of Pharmacy, University of California, San Francisco.
McQueen
K D
KD
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001262:Atenolol / Q000627:therapeutic use*; D001569:Benzodiazepines / Q000627:therapeutic use; D004311:Double-Blind Method; D000431:Ethanol / Q000009:adverse effects*; D006801:Humans; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D000319:Adrenergic beta-Antagonists; D001569:Benzodiazepines; D000431:Ethanol; D001262:Atenolol